The Yin and Yen of GABA in Brain Development and Operation in Health and Disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. SLC12A2 variants cause a neurodevelopmental disorder or cochleovestibular defect.Brain : a journal of neurology · 2020
   Article
2. miRNAs-dependent regulation of synapse formation and function.Genes & genomics · 2020
   Review
3. Sodium Transporters in Human Health and Disease.Frontiers in physiology · 2020
   Review
4. Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth.Scientific reports · 2019
   Article
5. Rodent Models of Developmental Ischemic Stroke for Translational Research: Strengths and Weaknesses.Neural plasticity · 2019
   Review
6. Calling in the CaFrontiers in cellular and infection microbiology · 2019
   Review
7. Taurine activates GABAergic networks in the neocortex of immature mice.Frontiers in cellular neuroscience · 2014
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.